C548-3183 Screening compound: 4-({2-[4-(2,5-dimethylphenyl)piperazine-1-carbonyl]pyrrolidin-1-yl}sulfonyl)-2,1,3-benzothiadiazole

C548-3183 Screening compound: 4-({2-[4-(2,5-dimethylphenyl)piperazine-1-carbonyl]pyrrolidin-1-yl}sulfonyl)-2,1,3-benzothiadiazole
C548-3183 Screening compound: 4-({2-[4-(2,5-dimethylphenyl)piperazine-1-carbonyl]pyrrolidin-1-yl}sulfonyl)-2,1,3-benzothiadiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound C548-3183
4-({2-[4-(2,5-dimethylphenyl)piperazine-1-carbonyl]pyrrolidin-1-yl}sulfonyl)-2,1,3-benzothiadiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C548-3183

Molecular Formula

C23H27N5O3S2 (C23 H27 N5 O3 S2)

Compound Name

4-({2-[4-(2,5-dimethylphenyl)piperazine-1-carbonyl]pyrrolidin-1-yl}sulfonyl)-2,1,3-benzothiadiazole

IUPAC name

4-({2-[4-(25-dimethylphenyl)piperazine-1-carbonyl]pyrrolidin-1-yl}sulfonyl)-213-benzothiadiazole

SMILES

Cc1cc(N(CC2)CCN2C(C(CCC2)N2S(c2cccc3nsnc23)(=O)=O)=O)c(C)cc1

InChI

InChI=1S/C23H27N5O3S2/c1-16-8-9-17(2)20(15-16)26-11-13-27(14-12-26)23(29)19-6-4-10-28(19)33(30,31)21-7-3-5-18-22(21)25-32-24-18/h3,5,7-9,15,19H,4,6,10-14H2,1-2H3/t19-/m0/s1

InChI Key

BPWODUKSISHBEH-IBGZPJMESA-N

MDL Number (MFCD)

MFCD14769535

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

485.63

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.679

Distribution Coefficient, logD

3.679

Water Solubility, LogSw

-3.94

Polar Surface Area

73.347

Acid Dissociation Constant (pKa)

20.25

Base Dissociation Constant (pKb)

3.55

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

43.50

C548-3183 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Neuropeptide S Library (2850 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Nervous system
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Structure:
  • Mimetics
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with C548-3183 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C548-3183?
Check Price and Availability of C548-3183, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C548-3183 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C548-3183
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C548-3183
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C548-3183 available by request